Journal of Anaesthesia & Critical Care Case Reports

Vol 7 | Issue 1 | January-April 2021 | Page 04-07 | Joseph A. McGuire, Paul McCarthy, Robert Herron, J.W. Awori Hayanga, Veena Nandwani, James Fugett, Heather K. Hayanga

Author: Joseph A. McGuire [1], Paul McCarthy [2], Robert Herron [3], J.W. Awori Hayanga [3], Veena Nandwani [3], James Fugett [4], Heather K. Hayanga [5]

[1] West Virginia University School of Medicine.
[2] Division of Critical Care, Department of Medicine, West Virginia University.
[3] Department of Cardiovascular and Thoracic Surgery, West Virginia University.
[4] West Virginia School of Osteopathic Medicine.
[5] Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology, West Virginia University.

Address of Correspondence
Dr. Joseph A. McGuire,
West Virginia University School of Medicine.
E-mail: jamcguire@mix.wvu.edu

Extracorporeal Life Support for Massive Hemoptysis and Acute Lung Injury Due to ANCA- Negative Vasculitis

Abstract

Massive hemoptysis is life-threatening and extracorporeal membrane oxygenation (ECMO) may be indicated as rescue therapy due to acute lung injury in this setting. We report a case of a patient who presented with massive hemoptysis and acute lung injury after reported inhaled ground oxymorphone abuse. Although initially thought to have been due to inhaled oxymorphone, we determined that the patient had ANCA-negative vasculitis that led to both hemoptysis and hematuria. The role of inhaled oxymorphone in combination with the vasculitis is unknown. ECMO was initiated to support the patient and, although his course was complicated, he did recover.
Keywords: ECMO; Vasculitis; Acute Respiratory Distress (ARDS).

References

1. Sakr, L., & Dutau, H. (2010). Massive hemoptysis: An update on the role of bronchoscopy in diagnosis and management. Respiration; International Review of Thoracic Diseases, 80(1), 38–58. https://doi.org/10.1159/000274492
2. Savage, C. O. S., Harper, L., Cockwell, P., Adu, D., & Howie, A. J. (2000). Vasculitis. BMJ : British Medical Journal, 320(7245), 1325–1328.
3. Endicott-Yazdani, T. R., Wood, C., Trinh, A. D., & Mora, A. (2018). Massive hemoptysis managed by rescue extracorporeal membrane oxygenation. Proceedings (Baylor University. Medical Center), 31(4), 479–481. https://doi.org/10.1080/08998280.2018.1487693
4. Yoo, J.-H., Kang, H. M., Choi, C. W., Park, M. J., & Lee, J. H. (2012). Extracorporeal membrane oxygenation as bridge in patients with non-iatrogenic massive hemoptysis. European Respiratory Journal, 40(Suppl 56). https://erj.ersjournals.com/content/40/Suppl_56/P1996
5. Kazuma, S. (2016). Almost Total Airway Obstruction Due to Unidentified Massive Hemoptysis under Extracorporeal Membrane Oxygenation. International Journal of Critical Care and Emergency Medicine, 2(1). https://doi.org/10.23937/2474-3674/1510012
6. Thiagarajan, R. R., Barbaro, R. P., Rycus, P. T., Mcmullan, D. M., Conrad, S. A., Fortenberry, J. D., Paden, M. L., & Centers, on behalf of the E. member. (2017). Extracorporeal Life Support Organization Registry International Report 2016. ASAIO Journal, 63(1), 60. https://doi.org/10.1097/MAT.0000000000000475
7. Greenberg, K., & Kohl, B. (2018). ECMO used successfully in a near fatal case of opioid-induced acute respiratory distress syndrome. The American Journal of Emergency Medicine, 36(2), 343.e5-343.e6. https://doi.org/10.1016/j.ajem.2017.11.020
8. Wilson, M. W., Bonnecaze, A. K., Dharod, A., & Miller, P. J. (2017). Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone. Southern Medical Journal, 110(3), 217–222. https://doi.org/10.14423/SMJ.0000000000000624
9. Hunt, R., Yalamanoglu, A., Tumlin, J., Schiller, T., Baek, J. H., Wu, A., Fogo, A. B., Yang, H., Wong, E., Miller, P., Buehler, P. W., & Kimchi-Sarfaty, C. (2017). A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER. Blood, 129(7), 896–905. https://doi.org/10.1182/blood-2016-08-736579
10. Suresh, E. (2006). Diagnostic approach to patients with suspected vasculitis. Postgraduate Medical Journal, 82(970), 483–488. https://doi.org/10.1136/pgmj.2005.042648
11. Turesson, C., Schaid, D. J., Weyand, C. M., Jacobsson, L. T., Goronzy, J. J., Petersson, I. F., Dechant, S. A., Nyähll-Wåhlin, B.-M., Truedsson, L., Sturfelt, G., & Matteson, E. L. (2006). Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis and Rheumatism, 54(9), 2776–2783. https://doi.org/10.1002/art.22057
12. Ahmed, S. H., Aziz, T., Cochran, J., & Highland, K. (2004). Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest, 126(1), 305–309. https://doi.org/10.1378/chest.126.1.305
13. Suzuki, M., Yokota, T., Gomei, S., Saiki, T., Kamisasanuki, T., Hayamizu, A., Sugiki, D., & Ikegami, K. (2016). Life-saving veno venous extracorporeal membrane oxygenation (VV-ECMO) in a case of potentially fatal massive hemoptysis due to bronchiectasis: A case report. Journal of the Japanese Society of Intensive Care Medicine, 23(3), 324–327. https://doi.org/10.3918/jsicm.23.324
14. Watts, R. A., Lane, S. E., Bentham, G., & Scott, D. G. (2000). Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis and Rheumatism, 43(2), 414–419. https://doi.org/10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0

(Abstract) (Text HTML) (Download PDF)